Physician profile
Gerald S Asin
NPI 1770576365
$42,959.39
in general payments reported to CMS, 2019-2025
81 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $5,698 · 2020: $3,476 · 2021: $4,697 · 2022: $3,264 · 2023: $5,172 · 2024: $4,635 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $9,263 · Travel and Lodging: $5,412 · Education: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,859.50 |
| Consulting Fee | $9,262.50 |
| Travel and Lodging | $5,411.66 |
| Education | $290.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $7,788.86 | 2019-2025 | Jardiance, Stiolto Respimat |
| Eisai INC. | $5,509.14 | 2020-2025 | |
| Abbvie INC. | $4,400.50 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $3,004.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Shionogi INC | $2,337.50 | 2023-2024 | |
| Lilly USA, LLC | $2,090.21 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $1,607.94 | 2019-2025 | Repatha, Otezla, Evenity |
| Biohaven Pharmaceuticals, INC. | $1,416.84 | 2020-2021 | |
| Pfizer INC. | $1,076.40 | 2019-2025 | |
| Allergan, INC. | $1,018.66 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $1,005.72 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $880.55 | 2019-2025 | Spravato |
| Glaxosmithkline, LLC. | $879.35 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $813.64 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $793.00 | 2019-2023 |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $778.60 | 2019-2023 | Trintellix, Glassia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $683.07 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Novartis Pharmaceuticals Corporation | $524.79 | 2019-2025 | |
| Astellas Pharma US INC | $486.17 | 2021-2025 | Veozah |
| Gilead Sciences, INC. | $351.64 | 2019-2025 | Yeztugo |
| Abbott Laboratories | $328.79 | 2019-2025 | Freestyle Libre 3, Eterna, Assurity |
| Antares Pharma, INC. | $262.96 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Sumitomo Pharma America, INC. | $208.30 | 2023-2025 | Gemtesa |
| Nestle Healthcare Nutrition INC. | $197.18 | 2021-2023 | |
| Mannkind Corporation | $187.47 | 2019-2024 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $178.92 | 2022 | |
| Amarin Pharma, INC. | $178.18 | 2019-2021 | |
| Dexcom, INC. | $172.59 | 2023-2025 | Dexcom G6 Transmitter |
| Avanir Pharmaceuticals, INC. | $170.95 | 2019-2022 | |
| Corcept Therapeutics | $149.26 | 2019-2025 | Korlym |
| Clarus Therapeutics INC. | $148.93 | 2021 | |
| Esperion Therapeutics, INC. | $147.71 | 2020-2024 | Nexletol |
| Octapharma USA, INC. | $144.29 | 2020 | |
| Lundbeck LLC | $140.32 | 2023-2025 | Rexulti, Vyepti |
| Merck Sharp & Dohme LLC | $136.77 | 2019-2024 | Dificid |
| Teva Pharmaceuticals USA, INC. | $131.02 | 2019-2023 | Ajovy |
| Otsuka America Pharmaceutical, INC. | $127.48 | 2021-2025 | Rexulti |
| Radius Health, INC. | $126.59 | 2019-2021 | |
| Aimmune Therapeutics, INC. | $126.22 | 2024-2025 | Zenpep |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $124.97 | 2023-2025 | Caplyta |
| Axsome Therapeutics, INC. | $123.93 | 2024-2025 | Auvelity, Sunosi |
| Tolmar, INC. | $121.29 | 2024-2025 | Jatenzo |
| Almatica Pharma LLC | $114.10 | 2023 | Loreev Xr |
| Lucid Diagnostics INC. | $108.51 | 2022-2024 | |
| Alfasigma USA, INC. | $105.97 | 2020-2022 | |
| Bausch Health US, LLC | $105.81 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $98.79 | 2022-2024 | Contrave, Nexletol, Nexlizet |
| Scilex Pharmaceuticals INC. | $95.04 | 2019-2024 | |
| Exact Sciences Corporation | $94.89 | 2023-2025 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $93.92 | 2020-2024 | |
| Therapeuticsmd, INC. | $83.16 | 2019-2020 | |
| Intra-Sana Laboratories | $79.08 | 2023-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Impel Pharmaceuticals INC. | $78.74 | 2022-2023 | Trudhesa |
| Medtronic, INC. | $76.33 | 2021-2025 | Minimed 780g |
| Boston Scientific Corporation | $70.25 | 2020-2023 | Watchman Access System |
| Idorsia Pharmaceuticals US INC | $65.71 | 2022-2023 | Quviviq |
| Shire North American Group INC | $57.37 | 2019 | |
| Becton, Dickinson and Company | $49.77 | 2021 | |
| Xeris Pharmaceuticals, INC. | $42.98 | 2020 | |
| Axonics, INC. | $41.58 | 2022-2023 | Axonics |
| Acerus Pharmaceuticals Corporation | $40.13 | 2022 | |
| Tempus Ai, INC | $36.11 | 2024-2025 | Tempus Pixel, Tempus Pixel |
| Verity Pharmaceuticals INC. | $35.15 | 2024-2025 | Tlando |
| Sanofi Pasteur INC. | $35.05 | 2019-2020 | |
| Verona Pharma, INC. | $30.41 | 2025 | Ohtuvayre |
| Seqirus USA INC | $22.59 | 2024 | Flucelvax, Fluad |
| Ge Healthcare | $20.77 | 2025 | |
| Mdd US Operations, LLC | $19.01 | 2021 | |
| Mylan Specialty L.P. | $18.99 | 2019 | |
| Sunovion Pharmaceuticals INC. | $17.86 | 2019 | |
| Amneal Pharmaceuticals LLC | $17.39 | 2024 | Unithroid |
| Medtronic USA, INC. | $16.85 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $16.57 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.49 | 2019 | |
| Acella Pharmaceuticals, LLC | $15.29 | 2025 | NP Thyroid 60 |
| Tonix Medicines, INC. | $13.74 | 2025 | Tonmya |
| Phadia US INC. | $13.56 | 2025 | Immunocap |
| Tandem Diabetes Care, INC. | $13.42 | 2021 | |
| Cequr Corporation | $10.72 | 2025 | Cequr Simplicity |
| Phathom Pharmaceuticals, INC. | $7.15 | 2025 | Voquezna |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$99,283.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Asin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.